SingleCell Biotechnology, a biotechnology company developing technologies to measure tumor cell behavior at single-cell ...

The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

Four biotech stocks in the IBD 50 are in bases as first-quarter earnings rolls in. Travere Therepeutics is below a buy point ...

The Biotechnology Innovation Organization (BIO) has started the nationwide “​The Fight of Our Lives” campaign, creating a ...

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

Co-founder of more than 40 biotechnology companies, including 16 IPOs and 19 successful acquisitions Scientific and medical titan focused on driving innovation for human healthWill assist with listeri ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes ...

Dozens of Massachusetts workers are about to lose their jobs after the FDA rejected a promising cancer drug — for the second ...

This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...

LifeSciencesNY, a trade group based in Central New York, urges state legislators to fund this effort in the upcoming state ...